Загрузка...
Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma
Gastric adenocarcinoma most often presents at an advanced stage and overall five-year survival of ~30%. Pharmacological ascorbate (high-dose IV ascorbate) has been proposed as a promising nontoxic adjuvant to standard radio-chemotherapies in several cancer types. In the current study, pharmacologica...
Сохранить в:
| Опубликовано в: : | Radiat Res |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6117840/ https://ncbi.nlm.nih.gov/pubmed/29547353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR14978.1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|